NCT05772104View on ClinicalTrials.gov

Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder

PHASE3RecruitingINTERVENTIONAL
Enrollment

495

Participants

Timeline

Start Date

April 17, 2023

Primary Completion Date

February 28, 2025

Study Completion Date

June 1, 2025

Conditions
Generalized Anxiety Disorder
Interventions
DRUG

Shugan Jieyu Capsules

Oral, 4 Capsules, BID

DRUG

Shugan Jieyu Capsules Placebo

"Drug: Shugan Jieyu Capsules Placebo, Oral，4 capsules，BID~Drug: Placebo, Oral, 1 capsule, BID"

Trial Locations (1)

Unknown

RECRUITING

Beijing Anding Hospital Affiliated to Capital Medical University, Beijing

All Listed Sponsors
lead

Sichuan Jishengtang Pharmaceutical Co., Ltd.

INDUSTRY